Dr. Matteo Simonelli, MD
Claim this profileIstituto Clinico Humanitas
Area of expertise
Brain Tumor
Matteo Simonelli, MD has run 4 trials for Brain Tumor. Some of their research focus areas include:
Cancer
Matteo Simonelli, MD has run 2 trials for Cancer. Some of their research focus areas include:
Clinical Trials Matteo Simonelli, MD is currently running
BMS-986340 + Nivolumab/Docetaxel
for Cancer
This trial tests a new drug, BMS-986340, alone and with other cancer treatments (nivolumab and docetaxel) in patients with advanced solid tumors. The goal is to find out if it is safe and effective in treating these cancers.
Recruiting
1 award
Phase 1 & 2
6 criteria
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting
1 award
Phase 3
More about Matteo Simonelli, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Matteo Simonelli, MD has experience with
- Nivolumab
- BMS-986253
- Ipilimumab
- Radiotherapy
- Temozolomide
- Surgery
Breakdown of trials Matteo Simonelli, MD has run
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matteo Simonelli, MD specialize in?
Matteo Simonelli, MD focuses on Brain Tumor and Cancer. In particular, much of their work with Brain Tumor has involved H3 K27M positive patients, or patients who are MET positive.
Is Matteo Simonelli, MD currently recruiting for clinical trials?
Yes, Matteo Simonelli, MD is currently recruiting for 2 clinical trials in Rozzano Lombardia. If you're interested in participating, you should apply.
Are there any treatments that Matteo Simonelli, MD has studied deeply?
Yes, Matteo Simonelli, MD has studied treatments such as Nivolumab, BMS-986253, Ipilimumab.
What is the best way to schedule an appointment with Matteo Simonelli, MD?
Apply for one of the trials that Matteo Simonelli, MD is conducting.
What is the office address of Matteo Simonelli, MD?
The office of Matteo Simonelli, MD is located at: Istituto Clinico Humanitas, Rozzano, Lombardia 20089 Italy. This is the address for their practice at the Istituto Clinico Humanitas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.